Tue, Mar 3, 2015, 11:08 AM EST - U.S. Markets close in 4 hrs 52 mins


% | $
Quotes you view appear here for quick access.

Nxstage Medical, Inc. Message Board

  • aaktx2 aaktx2 Oct 1, 2011 3:26 PM Flag

    A patient's advocate

    The push is for "home"modalities. This is an underperformer. A patient needs to have a partner, a usable fistula, and be schooled in the "button-hole" technique. The middle-molecule clearance is sub-optimal and larger particles are removed poorly(Bet 2 Microglobin, phos). For the added advantage of convenience and better control of interdialytic wt gain/BP, your patients remain uremic with next stage devices. Your patients who weigh over 75kg will not achieve adequate clearance of single poot KT/V or equilibrated specimens. Sell it fast before people realize what they are doing offering this modality.

16.82-0.27(-1.58%)11:06 AMEST

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.